<unk>  is an antimalarial drug. It was first made in 1970 and has been in clinical use in China since the 1980s. It is one of the components of the artemisinin combination therapy<unk> /artesunate (Pyramax). It has also been studied as a potential anticancer drug, and treatment for Ebola. The combination of<unk>  and artesunate has been evaluated to have a synergistic effect of stronger antiviral effect and less toxicity. The combination of<unk>  and artesunate is being studied as a possible treatment for moderate to severe SARS-COV-2.
Pyronaridine
Diiodohydroxyquinoline
Metirosine
Corynanthine
Deoxygedunin
Furan
Dimethyl methylphosphonate
Folinic acid